Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy

Journal of Surgical Oncology

Volumn 100, Issue 4, 2009, Pages 287-292

  González Moreno, Santiago ^a   Ortega Pérez, Gloria ^a   González Bayón, Luis ^a  

^a MD ANDERSON CANCER CENTER   (Spain)

Author keywords

Cytoreduction; Hyperthermia; Peritoneal carcinomatosis; Regional chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; PATIENT SELECTION; PERIOPERATIVE PERIOD; PERITONEUM CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; PATIENT SELECTION; PERITONEAL NEOPLASMS;

EID: 69749095480     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21325     Document Type: Conference Paper

References (38)

1. Sugarbaker PH: Management of peritoneal surface malignancy: A short history. Recent Results Cancer Res 2007;169:1-9.
2. Yan TD, Welch L, Black D, et al.: A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2007;18:827-834. (Pubitemid 47054078)
3. Yan TD, Black D, Savady R, et al.: A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2007;14:484-492. (Pubitemid 46175292)
4. Yan TD, Black D, Savady R, et al.: Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24:4011-4019. (Pubitemid 46630752)
5. Yonemura Y, Bando E, Kawamura T, et al.: Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. Cancer Treat Res 2007;134:357-373.
6. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-796. (Pubitemid 30013658)
7. Moran BJ: Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf) 2006;28:375-378.
8. Smeenk RM, Verwaal VJ, Zoetmulder FA: Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007;94:1408-1414.
9. Yan TD, Links M, Fransi S, et al.: Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy - A journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 2007;14:2270-2280. (Pubitemid 47174916)
10. Sugarbaker PH, Garofalo A, González-Moreno S (eds.): Special issue: Peritoneal surface malignancy. Eur J Surg Oncol 2006;32:593-691.
11. Special issue: Dedicated to the 5th International Consensus Meeting on Peritoneal Surface Malignancies Treatment. J Surg Oncol 2008;98:215-305.
12. González-Moreno S, Kusamura S, Baratti D, et al.: Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 2008;98:237-241.
13. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727-731.
14. Verwaal VJ, Kusamura S, Baratti D, et al.: The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol 2008;98:220-223.
15. Yan TD, Morris DL, Kusamura S, et al.: Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Surg Oncol 2008;98:224-227.
16. Elias D, Benizri E, Pocard M, et al.: Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 2006;32:632-636. (Pubitemid 44064000)
17. Dromain C, Leboulleux S, Auperin A, et al.: Staging of peritoneal carcinomatosis: Enhanced CT vs. PET/CT. Abdom Imaging 2008;33:87-93.
18. de Bree E, Koops W, Kröger R, et al.: Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2006;32:65-71. (Pubitemid 43103990)
19. Jacquet P, Jelinek JS, Chang D, et al.: Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 1995;181:530-538.
20. Yan TD, Haveric N, Carmignani CP, et al.: Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 2005;103:839-849. (Pubitemid 40216414)
21. Low RN: Magnetic resonance imaging in the oncology patient: Evaluation of the extrahepatic abdomen. Semin Ultrasound CT MR 2005; 224-236. (Pubitemid 41111580)
22. Ordóñez NG: Pathologic characterization and differential diagnosis of malignant peritoneal mesothelioma. Recent Results Cancer Res 2007;169:123-136.
23. Ronnett BM, Yan H, Kurman RJ, et al.: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:85-91. (Pubitemid 32623044)
24. Gomes da Silva R, Cabanas J, Sugarbaker PH: Limited survival in the treatment of carcinomatosis from rectal cancer. Dis Colon Rectum 2005;48:2258-2263. (Pubitemid 43074446)
25. Hassan R, Alexander R, Antman K, et al.: Current treatment options and biology of peritoneal mesothelioma: Meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol 2006;17:1615-1619. (Pubitemid 44680879)
26. Markman M: Intraperitoneal chemotherapy in the management of ovarian cancer. Recent Results Cancer Res 2007;169:165-176.
27. Armstrong DK, Bundy B, Wenzel L, et al.: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34-43. (Pubitemid 43048949)
28. Helm CW, Bristow RE, Kusamura S, et al.: Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 2008;98:283-290.
29. Rufián S, Muñoz-Casares FC, Briceño J, et al.: Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. J Surg Oncol 2006;94:316-324. (Pubitemid 44330855)
30. Rossi CR, Casali P, Kusamura S, et al.: The consensus statement on the locoregional treatment of abdominal sarcomatosis. J Surg Oncol 2008;98:291-294.
31. Gil A, Gomez Portilla A, Brun EA, et al.: Clinical perspective on desmoplastic small round-cell tumor. Oncology 2004;67:231-242. (Pubitemid 39551707)
32. McQuellon R, Gavazzi C, Piso P: Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): Recommendations for care. J Surg Oncol 2008;98:300-305.
33. González Bayón L, Sugarbaker PH, Gonzalez Moreno S, et al.: Initiation of a program in peritoneal surface malignancy. Surg Oncol Clin N Am 2003;12:741-753. (Pubitemid 36920096)
34. Pestieau SR, Sugarbaker PH: Treatment of primary colon cancer with peritoneal carcinomatosis: Comparison of concomitant vs. delayed management. Dis Colon Rectum 2000;43:1341-1346.
35. González-Moreno S, Sugarbaker PH: Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004;91:304-311. (Pubitemid 38375769)
36. González-Moreno S: Surgical management of peritoneal carcinomatosis: From clinical research to standard of care. Clin Transl Oncol 2006;8:545-546.
37. González-Moreno S: Peritoneal Surface Oncology: A progress report. Eur J Surg Oncol 2006;32:593-596.
38. Elias D, Goéré D, Di Pietrantonio D, et al.: Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2008;247:445-450.